Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: not anytime soon.
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Copied and pasted from today's 10-Q

While we currently do not expect to list our securities on the Nasdaq Stock Market or other national exchange until after we have filed our Annual Report on Form 10-K for the year ending December 31, 2021, the Board of Directors may implement the reverse stock split at any time on or before June 25, 2022.

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply